Cervical Cancer Kills Nearly 1,000 Malaysian Women Each Year. The Country Already Has the Tools to Stop It

Key Insights ▼

Every year in Malaysia, close to 1,000 women die from cervical cancer — a disease that the world now agrees no woman should die from it.

According to the National Cancer Registry, about 1,740 new cases are diagnosed annually, making cervical cancer one of the most common cancers affecting Malaysian women.

The numbers tell a hard truth: this is not a failure of medicine. It is a failure of information dissemination and access.

A common cancer that arrives too late

Cervical cancer is the third most common cancer among women in Malaysia, with an age‑standardised incidence rate of 6.2 per 100,000 women (2012–2016). More recent national data place it as the sixth most common cancer, reflecting progress — but also persistent gaps.

Between 2017 and 2021, one in two Malaysian women with cervical cancer was diagnosed at advanced stages (Stage III or IV), when treatment is more complex, more costly, and far less likely to succeed.

A preventable disease driven by a common virus

More than 95% of cervical cancer cases are caused by persistent infection with human papillomavirus (HPV), a virus transmitted through sexual contact and so widespread that most people encounter it at some point in their lives.

In most women, the immune system clears HPV naturally. When high‑risk strains — particularly HPV‑16 and HPV‑18 — persist for years, they can trigger cellular changes that lead to cancer.

Regular screening through Pap smears or HPV tests, combined with HPV vaccination, can stop the disease before it starts. Few cancers offer such a clear path to prevention.

Malaysia’s success story — and who is still left out

Malaysia’s national HPV vaccination programme, delivered through schools, has been a public‑health success. By offering the vaccine to schoolgirls, the programme has achieved high coverage rates, helping to protect an entire generation of young women from future cervical cancer risk.

Delivering the HPV vaccine through schools has been one of the most effective ways to reach girls early. It works because it removes cost, stigma, and access barriers.

But not everyone benefits equally.

Girls from undocumented or stateless families, those who have dropped out of school, and communities with low health literacy often miss out — leaving them vulnerable to a disease that is almost entirely preventable.

“Leaving no one behind”

To close these gaps, the National Cancer Society Malaysia (NCSM) launched the “Leaving No One Behind” (LNOB) initiative in 2023.

Working with community leaders, schools, local councils, and private healthcare providers, NCSM delivered 287,280 fully subsidised HPV vaccine doses across 16 states and 141 districts.

“Our target group was basically the underserved communities where HPV vaccination was not easily available — communities facing barriers or challenges in getting the vaccine,” says Datuk Dr Saunthari Somasundaram, President of NCSM.

The effort reflects a growing recognition that elimination is not just about national averages, but about reaching those on the margins.

A global commitment Malaysia is part of

The push to eliminate cervical cancer is not only national — it is global.

In May 2018, the Director‑General of the World Health Organization (WHO) issued a global call to action to eliminate cervical cancer, stating plainly:

“No woman should die from cervical cancer. We have the technical, medical and policy tools and approaches to eliminate it.”

In 2019, WHO member states committed to a Global Strategy to eliminate cervical cancer as a public‑health problem, setting clear targets for 2020–2030:

90% of girls fully vaccinated against HPV
70% of women screened at least twice in their lifetime
90% of women with precancer or cancer receiving treatment

The burden of the disease, WHO warns, continues to fall disproportionately on women who lack access to health services, particularly in low‑ and middle‑income countries.

The clock is still ticking

Cervical cancer often develops silently. Early stages cause no pain, no warning signs. When symptoms such as abnormal bleeding or pelvic pain appear, the disease is frequently advanced.

This is why screening matters — and why late diagnosis remains deadly.

Malaysia has made real progress. Vaccination works. Screening saves lives. Community initiatives are reaching those once overlooked.

What remains is consistency, inclusion, information dissemination and political resolve to ensure no woman is missed.

Cervical cancer is not a medical puzzle waiting to be solved. It is a test of whether prevention reaches every woman, regardless of income, legal status, or education.

Until it does, nearly 1,000 Malaysian women a year will continue to die from a disease the world already knows how to stop.

Disclaimer: This article is for informational purposes only and does not replace professional medical advice.

Disclaimer: Editorial content on this site is for general information only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider with any questions about your health. While we take care to ensure accuracy, we make no guarantees and accept no responsibility for any errors, omissions, outdated information or any consequences arising from use of this site. Views expressed in articles, interviews and features are those of the authors or contributors and do not necessarily reflect the views of the publisher. References to, or advertisements for, products or services do not constitute endorsements, and we do not guarantee their quality, safety or effectiveness. You can read our editorial policy.